Results
625
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
625 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
600760 | CN¥47.98 | 1.8% | 30.8% | CN¥132.2b | CN¥53.90 | PE53.7x | E29.3% | 0.8% | Capital Goods | ||
RHM | €694.40 | 6.8% | 110.2% | €30.1b | €725.20 | PE44x | E29.9% | 0.8% | Capital Goods | ||
9992 | HK$87.60 | 2.7% | 367.4% | HK$116.2b | HK$96.02 | PE71.6x | E35.8% | 0.3% | Retail | ||
ALNY | US$246.27 | 3.5% | 33.8% | US$32.1b | US$298.97 | PS15.2x | E56.4% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$80.02 | 8.4% | 285.1% | US$12.6b | US$77.77 | PS54.5x | E66.3% | n/a | Semiconductors | ||
ARES | US$191.32 | 9.3% | 64.3% | US$58.8b | US$188.92 | PE89.3x | E38.4% | 1.9% | Diversified Financials | ||
ONON | US$57.98 | 2.4% | 107.4% | US$18.0b | US$60.77 | PE134.8x | E29.7% | n/a | Consumer Durables | ||
EXEL | US$36.20 | 0.5% | 61.0% | US$10.4b | US$35.61 | PE22.1x | E20.9% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$137.71 | 1.3% | 131.5% | US$3.4t | US$173.08 | PE53.5x | E24.4% | 0.03% | Semiconductors | ||
511243 | ₹1,258.45 | 0.3% | -0.6% | ₹1.1t | ₹1,509.06 | PE27.5x | E21.5% | 0.2% | Diversified Financials | ||
300308 | CN¥116.90 | 3.3% | 47.4% | CN¥129.1b | CN¥197.44 | PE27.9x | E33.0% | 0.3% | Tech | ||
NU | US$11.53 | 5.3% | 25.7% | US$54.2b | US$15.19 | PB7.2x | E25.3% | n/a | Banks | ||
MRVL | US$124.76 | 9.1% | 75.5% | US$101.7b | US$127.43 | PS20.1x | E69.5% | 0.2% | Semiconductors | ||
2345 | NT$734.00 | 0.7% | 42.0% | NT$410.2b | NT$789.38 | PE42.2x | E25.1% | 1.4% | Tech | ||
300502 | CN¥119.43 | 10.3% | 134.0% | CN¥84.7b | CN¥160.74 | PE44.4x | E36.6% | 0.1% | Tech | ||
A196170 | ₩307,500.00 | -0.6% | 306.7% | ₩16.4t | ₩565,000.00 | PS220.3x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
BESI | €147.10 | 2.2% | 2.3% | €11.7b | €146.00 | PE66x | E25.4% | 1.5% | Semiconductors | ||
SOLARINDS | ₹9,713.40 | 1.9% | 40.0% | ₹879.0b | ₹11,698.00 | PE87x | E27.0% | 0.09% | Materials | ||
PME | AU$248.70 | -7.3% | 149.5% | AU$26.0b | AU$213.44 | PE313.9x | E22.4% | 0.2% | Healthcare | ||
600989 | CN¥17.06 | 3.1% | 21.0% | CN¥125.1b | CN¥21.74 | PE19.9x | E38.5% | 1.6% | Materials | ||
KSPI | US$92.87 | 1.4% | -3.2% | US$17.4b | US$130.76 | PE9.6x | E23.7% | 6.9% | Diversified Financials | ||
SMCI | US$30.82 | -5.5% | -27.2% | US$18.2b | US$40.34 | PE14.9x | E24.3% | n/a | Tech | ||
ITCI | US$126.20 | 33.0% | 92.8% | US$13.4b | US$121.36 | PS21.8x | E52.2% | n/a | Pharmaceuticals & Biotech | ||
BAM | CA$80.36 | 6.9% | 53.1% | CA$33.3b | CA$73.97 | PE51.8x | E87.6% | 2.7% | Diversified Financials |